Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Senmiao Biotechnology is a Chinese life sciences company specializing in the research, development, and production of health products derived from natural sources, particularly Sea Buckthorn (Hippophae rhamnoides). Founded in 2003, the company operates across the entire value chain, from ecological cultivation to the manufacturing of functional foods, supplements, and cosmetics. Its product portfolio is centered on the therapeutic properties of sea buckthorn oil and extracts, targeting immune regulation, cardiovascular health, and anti-aging. The company is a key player in the industrialization of sea buckthorn-based health solutions in China and is recognized for integrating ecological restoration with biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Senmiao Biotechnology.